Optometrists in Berwyn Heights, MD Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Eye Associates Optometrist - Sports Vision Medicare: Not Enrolled in Medicare Practice Location: 5701 Greenbelt Rd, Berwyn Heights, MD 20740 Phone: 410-997-1800 Fax: 301-596-5070 |
My Eye Dr Optometrist Medicare: Medicare Enrolled Practice Location: 5701 Greenbelt Rd, Berwyn Heights, MD 20740 Phone: 301-345-2053 Fax: 301-441-1752 |
 Dr. Christopher Kollias, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5701 Greenbelt Rd, Berwyn Heights, MD 20740 Phone: 301-345-2053 Fax: 301-441-1752 |
Mr. Charles R Mund, OD. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5701 Greenbelt Rd, Berwyn Heights, MD 20740 Phone: 301-345-2053 Fax: 301-441-1752 |
Keith Versteegden, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5701 Greenbelt Rd, Berwyn Heights, MD 20740 Phone: 301-345-2053 Fax: 301-441-1752 |
News Archive
State highlights: Court hears arguments on Fla. 'gun-gag' law; Univ. of Minn. seeks to scale back coverage; fewer Utah docs see Medicaid patients
The top attorney for the state of Florida asked a federal appeals court today to reinstate a Florida law that regulates what physicians can ask patients about gun ownership, asserting that the law does not actually stifle such questions. Yes, it does, countered a lawyer representing several Florida medical societies and individual physicians who challenged the law as an infringement on their First Amendment right to free speech (Lowes, 7/18).
WHO advises earlier treatment for people with HIV
An estimated 5.2 million people were receiving life-saving HIV treatment at the end of 2009, according to the latest update from the WHO. WHO estimates that 1.2 million people started treatment in 2009, bringing the total number of people receiving treatment to 5.2 million, compared to 4 million at the end of 2008.
CYP1B1 protein may be a potential target for intervention in head and neck cancer
Squamous cell carcinoma of the head and neck-which typically arises from thin, flat cells that line moist surfaces inside the mouth, nose and throat-is the sixth most common type of cancer worldwide, and it has a relatively low five-year survival rate and a high recurrence rate.
Study on interactions between new antitubercular drug candidates SQ109 and TMC207
Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate:
› Verified 9 days ago